Browsing by Author "Atis, Guldehan"

Now showing 1 - 2 of 2

Hepatitis C and hepatitis B virus infections in the etiopathogenesis of pemphigus
(2014) Demirci, Gulsen Tukenmez; Aydingoz, Ikbal Esen; Mansur, Ayse Tulin; Atis, Guldehan; Altunay, Ilknur Kivanc
BACKGROUND: Previous studies have shown that some viral infections may be triggers for autoimmune diseases. The role of viral infections in the etiopathogenesis of pemphigus has also been investigated. OBJECTIVES: To investigate the relationship between pemphigus and the hepatitis B and C virus infections. METHODS: This retrospective study included 62 patients with pemphigus and 50 healthy controls of matching ages and genders. The control group included relatives who accompanied the orthopedic patients to the hospital but had no history of systemic and/or autoimmune diseases. RESULTS: The group of patients with pemphigus was composed of 43 (69.3%) females and 19 (29.7%) males, and the mean age was 48.08 +/- 15.38. The hepatitis C virus antibody was negative in all of the patients. Hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (HBsAb), or both, were studied in 44 of the 62 patients. Two (4.3%) of these patients were positive for HBsAg and found to have HBV infection. Fourteen of them were HBsAb positive. Two (4%) of the 50 control subjects showed hepatitis C virus antibody positivity, while only 1 (2%) patient with pemphigus displayed HBsAg positivity. There was no statistically significant difference between the two groups for hepatitis B and C virus infections. CONCLUSIONS: This study does not support an association between pemphigus and hepatitis B and/or C virus infections.
The investigation of the frequency of menstrual irregularity and hypertrichosis due to isotretinoine usage in female patients
(2014) Demirci, Gulsen Tukenmez; Mertsoylu, Eda; Altunay, Ilknur Kivanc; Atis, Guldehan; Kucukunal, Asli
Background and Design: To investigate the rate of hypertrichosis and menstrual irregularity in female patients receiving isotretinoin treatment. Materials and Methods: In our study, we included female acne patients who were started isotretinoin treatment and who had no history of menstrual irregularities and hypertrichosis within 6 months prior to isotretinoin use and had no any systemic disease and did not take any medicine except isotretinoin. They were started 0.5-0.8 mg/kg isotretinoin treatment and followed by routine laboratory tests until the total cumulative dose of isotretinoin therapy was completed. They were controlled if they had menstrual irregularity or hypertrichosis after starting isotretinoin. Results: Fifty-six patients were included in the study. The mean age of the patients was 24.91 +/- 5.72 years. The mean treatment period was 6.28 +/- 0.56 months. We found that 16 of 56 (28.8%) patients had menstrual irregularity. Six patients had prolonged interval (delay), -4, hypomenorrhea, -2, hypomenorrhea and prolonged interval, -2, metrorrhagia, - 1, shortened interval, and 1 patient had missed period. Of the 56 patients, 11 patients (23.8%) had hypertrichosis. 5 (45.45%) patients with hypertricchosis were found to have also menstrual irregularity while 5(31.25%) of 16 menstrual irregularity patients were found to have hypertrichosis. Nine patients reported having a stressful life event. One of them were both had menstrual irregularity and hypertrichosis, 2 of them had only hypertrichosis, 2 of them had only menstrual irregularity and 4 of them had no more finding. Conclusion: Our study showed that the complaints of menstrual irregularity and hypertrichosis may develop during isotretinoin therapy. Based on this result, we assume that further laboratory tests and controlled studies investigating the effects of isotretinoin on hormones are needed.